Scarica l'app Stockscreener
2.17
0.00%
0.00
Dopo l'orario di chiusura:
2.17
Precedente Chiudi:
$2.17
Aprire:
$2.17
Volume 24 ore:
2.86M
Relative Volume:
0.17
Capitalizzazione di mercato:
$274.90M
Reddito:
-
Utile/perdita netta:
$-112.46M
Rapporto P/E:
-1.3232
EPS:
-1.64
Flusso di cassa netto:
$-99.89M
1 W Prestazione:
+1.40%
1M Prestazione:
+5.85%
6M Prestazione:
+58.39%
1 anno Prestazione:
+135.87%
Intervallo 1D:
$2.09
$2.275
Intervallo di 1 settimana:
$1.97
$2.32
Portata 52W:
$0.1311
$3.29
Vor Biopharma Inc Stock (VOR) Company Profile
Nome
Vor Biopharma Inc
Settore
Industria
Telefono
617-655-6580
Indirizzo
100 CAMBRIDGEPARK DRIVE, CAMBRIDGE
Confronta VOR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VOR
Vor Biopharma Inc
|
2.17 | 258.43M | 0 | -112.46M | -99.89M | -1.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Vor Biopharma Inc Stock (VOR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-30 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2022-07-26 | Iniziato | Wedbush | Outperform |
| 2022-04-27 | Iniziato | Goldman | Neutral |
| 2021-12-17 | Iniziato | H.C. Wainwright | Buy |
| 2021-12-03 | Iniziato | Robert W. Baird | Outperform |
| 2021-12-02 | Iniziato | Oppenheimer | Outperform |
| 2021-10-19 | Iniziato | JMP Securities | Mkt Outperform |
| 2021-03-25 | Iniziato | B. Riley Securities | Buy |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2021-03-03 | Iniziato | Evercore ISI | Outperform |
| 2021-03-02 | Iniziato | Goldman | Sell |
| 2021-03-02 | Iniziato | Stifel | Buy |
Mostra tutto
Vor Biopharma Inc Borsa (VOR) Ultime notizie
Vor Biopharma Shares Rally After Positive Clinical Results Announced - StocksToTrade
Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
7 Million Stock Options: Vor Bio Awards Major Equity Package to New Biotech Talent - Stock Titan
Vor Biopharma Inc. Stock Poised for Technical ComebackJuly 2025 Trends & Accurate Technical Buy Alerts - newsimpact.co.kr
What MACD signals say about Vor Biopharma Inc.Breakout Watch & Weekly Chart Analysis and Guides - Newser
What institutional flow reveals about Vor Biopharma Inc.Earnings Overview Summary & Weekly Watchlist for Consistent Profits - Newser
Has Vor Biopharma Inc. formed a bullish divergenceJuly 2025 Price Swings & Weekly Hot Stock Watchlists - Newser
Best data tools to analyze Vor Biopharma Inc. stockEarnings Recap Summary & High Conviction Buy Zone Picks - Newser
What’s the MACD signal for Vor Biopharma Inc.2025 Market Outlook & Advanced Technical Signal Analysis - classian.co.kr
Why Vor Biopharma Inc. stock attracts strong analyst attentionJuly 2025 EndofMonth & Reliable Trade Execution Plans - Newser
What is Vor Biopharma Inc. s 5 year growth outlook2025 Volume Leaders & Low Drawdown Momentum Ideas - thegnnews.com
Chart overlay techniques for tracking Vor Biopharma Inc.Gap Up & Consistent Profit Focused Trading Strategies - Newser
HC Wainwright Reaffirms Buy Rating for Vor Biopharma (NYSE:VOR) - Defense World
Wedbush Comments on Vor Biopharma’s Q3 Earnings (NYSE:VOR) - Defense World
Vor Biopharma Inc. stock trend outlook and recovery pathPortfolio Update Summary & Daily Technical Stock Forecast Reports - Newser
Is Vor Biopharma Inc. stock reversal real or fakeQuarterly Profit Summary & Reliable Trade Execution Plans - Newser
Vor Biopharma Inc. Company’s Quarterly Earnings Growth: What the Numbers SayWatch List & Accurate Technical Buy Alerts - Newser
Screener Results Flag Vor Biopharma Inc. as OversoldRate Hike & Target Return Focused Picks - newsyoung.net
Technical Charts Suggest Momentum Shift in Vor Biopharma Inc.July 2025 Selloffs & Stock Timing and Entry Methods - newsyoung.net
Vor Biopharma: HC Wainwright Raises Buy Rating to $3, PT Raised to $3. - AInvest
Machine Learning Models Forecast Vor Biopharma Inc. UptickMarket Sentiment Report & Safe Capital Preservation Plans - sundaytimes.kr
Vor Biopharma Inc. Hits Price Floor — Bounce IncomingAnalyst Downgrade & High Accuracy Buy Signal Tips - newsyoung.net
Vor Biopharma's Unexpected Resurrection: A New Direction Amid Uncertainty. - AInvest
Vor Biopharma: Chinese Win Sets The Direction, But There Is Still Much Uncertainty - Seeking Alpha
Health Care Stocks Climb As Deals And Results Grab Attention - Finimize
Private Equity Firms Are Vor Biopharma Inc.'s (NASDAQ:VOR) Biggest Owners and Were Hit After Market Cap Dropped US$66m - 富途牛牛
Vor Bio Rallies On Strong Data For Autoimmune Drug Candidate - Benzinga
Vor Biopharma Skyrockets 19.72%—What’s Fueling This Biotech Breakout? - AInvest
Is Vor Bio Stock Soaring Too High? - StocksToTrade
Vor Bio, RemeGen succeed in trial for telitacicept in China - Seeking Alpha
Vor Biopharma Shares Jump After Phase 3 Telitacicept Study Achieves Primary Endpoint - MarketScreener
Surge in Vor Bio Stock: What’s Driving It? - timothysykes.com
Breakthrough for Sjögren's Disease: Vor Bio's Drug Shows Best-in-Disease Potential in Phase 3 - Stock Titan
Vor Biopharma Soars 9.04% on Bullish Analyst Forecast - AInvest
Vor Biopharma's High-Stakes Gamble: Can Telitacicept Justify the Burn? - AInvest
Vor Biopharma Inc (VOR) Stock: A Year of Highs and Lows in the Market - investchronicle.com
Borrow Rate Hikes Hit Vor Biopharma, Upexi, and Defiance 1.75x MSTR ETF Amid Market Volatility - AInvest
Is Vor Biopharma Inc. a strong growth stockBest Picks for Fast Turnaround - news-j.co.kr
Vor Biopharma VOR 2025Q2 Earnings Preview Upside Ahead on New Navigational Systems Integration - AInvest
Vor Biopharma Inc. (NASDAQ:VOR) Short Interest Update - MarketBeat
Vor Biopharma Inc expected to post a loss of 44 cents a shareEarnings Preview - TradingView
Intraday Charts Show Spike in Vor Biopharma Inc. ActivitySwing Trade Plans Emphasize Risk Management - metal.it
Vor Bio appoints seasoned biotech executive Dallan Murray as Chief Commercial Officer - MarketScreener
Vor Bio Appoints Seasoned Biotech Executive Dallan Murray as Chief Commercial Officer - GlobeNewswire
What are Vor Biopharma Inc. company’s key revenue driversDynamic investment opportunities - Jammu Links News
How volatile is Vor Biopharma Inc. stock compared to the marketBuild a portfolio with strong long-term growth - Jammu Links News
What institutional investors are buying Vor Biopharma Inc. stockAchieve breakthrough investment performance - Jammu Links News
Why is Vor Biopharma Inc. stock attracting strong analyst attentionBuild wealth faster with expert stock picks - Jammu Links News
What catalysts could drive Vor Biopharma Inc. stock higher in 2025Navigate market volatility with smart strategies - Jammu Links News
What drives Vor Biopharma Inc. stock priceInvest smarter with expert trading signals - Jammu Links News
How does Vor Biopharma Inc. generate profit in a changing economyHigh-impact stock picks - Jammu Links News
Vor Biopharma Inc Azioni (VOR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.94%
1.72%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):